A method for characterising serum fibrinogen and fibrin degradation products.

[1]  V. Kakkar,et al.  A comparison of the sulphite and thrombin methods for measuring fibrinogen concentration of plasma from patients undergoing thrombolytic therapy. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[2]  P. Gaffney,et al.  Distinction between fibrinogen and fibrin degradation products in plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[3]  V. Kakkar,et al.  TREATMENT OF DEEP-VEIN THROMBOSIS WITH INTERMITTENT STREPTOKINASE AND PLASMINOGEN INFUSION , 1975, The Lancet.

[4]  P. Gaffney,et al.  Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin. , 1975, Clinical science and molecular medicine.

[5]  T. Chard,et al.  SERUM FIBRIN(OGEN) DEGRADATION PRODUCTS IN DIAGNOSIS OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLISM AFTER HIP SURGERY , 1975, The Lancet.

[6]  V. Kakkar,et al.  Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. , 1975, Thrombosis research.

[7]  T. Edgington,et al.  A cleavage-associated neoantigenic marker for a gamma chain site in the NH2-terminal aspect of the fibrinogen molecule. , 1975, The Journal of biological chemistry.

[8]  T. Edgington,et al.  Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. , 1975, The Journal of biological chemistry.

[9]  V. Marder,et al.  Data for Defining Fibrinogen and Its Plasmic Degradation Products , 1975, Thrombosis and Haemostasis.

[10]  T. Chard,et al.  The Development of Radioimmunoassays for Fibrinogen Degradation Products: Fragments D and E , 1975, British journal of haematology.

[11]  P. Cuatrecasas,et al.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.

[12]  P. Gaffney,et al.  Plasma Fibrinogen and its Fragments during Streptokinase Treatment , 1974, British journal of haematology.

[13]  J. Gormsen,et al.  Demonstration of different D-and E-antigenic intermediates during plasmin degradation of non-stabilized and stabilized fibrin clots. , 2009, Scandinavian journal of haematology.

[14]  W. Hunter,et al.  The use of antisera covalently coupled to agarose, cellulose and sephadex in radioimmunoassay systems for proteins and haptens. , 1973, Biochimica et biophysica acta.

[15]  S. Pizzo,et al.  Subunit structure of fragment D from fibrinogen and cross-linked fibrin. , 1973, Journal of Biological Chemistry.

[16]  Garvey Mb,et al.  The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle. , 1972 .

[17]  P. Gaffney,et al.  A structural aspect of human fibrinogen suggested by its plasmin degradation , 1971, FEBS letters.

[18]  R. Colman,et al.  A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. , 1970, The New England journal of medicine.

[19]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[20]  V. Marder,et al.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. , 1969, The Journal of biological chemistry.

[21]  H. G. Clarke,et al.  Quantitative immunoelectrophoresis of human serum proteins. , 1968, Clinical science.

[22]  C. Merskey,et al.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. , 1966, Blood.